Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms. 1998

G J Nijeholt, and M A van Walderveen, and J A Castelijns, and J H van Waesberghe, and C Polman, and P Scheltens, and P F Rosier, and P J Jongen, and F Barkhof
Department of Radiology, Vrije Universiteit Hospital, Amsterdam, The Netherlands.

We investigated various magnetic resonance MRI parameters for both brain and spinal cord to see if any improved the clinicoradiological correlation in multiple sclerosis. Ninety-one multiple sclerosis patients (28 relapsing-remitting, 32 secondary progressive and 31 primary progressive) were imaged using conventional T1, proton density- and T2-weighted MRI of the brain and spinal cord. Focal brain and spinal cord lesion load was scored, as were diffuse signal abnormalities, brain ventricular volume and spinal cord cross-sectional area. Clinical measures included the expanded disability status scale (EDSS), the functional systems score and a dedicated urology complaint questionnaire. Secondary progressive patients differed from relapsing-remitting and primary progressive patients by a larger number of hypointense T1 lesions in the brain, ventricular enlargement and spinal cord atrophy. Primary progressive patients more often had diffuse abnormalities in the brain and/or spinal cord than did relapsing-remitting and secondary progressive patients. In the entire study population, EDSS correlated with both brain and spinal cord MRI parameters, which were independent. The urological complaint score correlated only with spinal cord MRI parameters. In relapsing-remitting and secondary progressive multiple sclerosis, the correlation between MRI and clinical parameters was better than in the entire population. In this subgroup EDSS variance could be explained best by T1 brain lesion load, ventricle volume and spinal cord cross-sectional area. In the primary progressive subgroup the clinicoradiological correlation was weak for brain parameters but was present between spinal cord symptoms and spinal cord MRI parameters. In conclusion, the different brain and spinal cord MRI parameters currently available revealed considerable heterogeneity between clinical subtypes of multiple sclerosis. In relapsing-remitting and secondary progressive multiple sclerosis both brain and spinal cord MRI may provide a tool for monitoring patients, while in primary progressive multiple sclerosis the clinicoradiological correlation is weak for brain imaging.

UI MeSH Term Description Entries
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D012075 Remission, Spontaneous A spontaneous diminution or abatement of a disease over time, without formal treatment. Spontaneous Healing,Spontaneous Regression,Spontaneous Remission,Healing, Spontaneous,Regression, Spontaneous,Spontaneous Healings,Spontaneous Regressions
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

G J Nijeholt, and M A van Walderveen, and J A Castelijns, and J H van Waesberghe, and C Polman, and P Scheltens, and P F Rosier, and P J Jongen, and F Barkhof
February 1991, Brain : a journal of neurology,
G J Nijeholt, and M A van Walderveen, and J A Castelijns, and J H van Waesberghe, and C Polman, and P Scheltens, and P F Rosier, and P J Jongen, and F Barkhof
August 2000, Muscle & nerve,
G J Nijeholt, and M A van Walderveen, and J A Castelijns, and J H van Waesberghe, and C Polman, and P Scheltens, and P F Rosier, and P J Jongen, and F Barkhof
June 1995, Radiology,
G J Nijeholt, and M A van Walderveen, and J A Castelijns, and J H van Waesberghe, and C Polman, and P Scheltens, and P F Rosier, and P J Jongen, and F Barkhof
February 2018, Neurologic clinics,
G J Nijeholt, and M A van Walderveen, and J A Castelijns, and J H van Waesberghe, and C Polman, and P Scheltens, and P F Rosier, and P J Jongen, and F Barkhof
September 2003, The Lancet. Neurology,
G J Nijeholt, and M A van Walderveen, and J A Castelijns, and J H van Waesberghe, and C Polman, and P Scheltens, and P F Rosier, and P J Jongen, and F Barkhof
April 2002, European radiology,
G J Nijeholt, and M A van Walderveen, and J A Castelijns, and J H van Waesberghe, and C Polman, and P Scheltens, and P F Rosier, and P J Jongen, and F Barkhof
January 1996, Journal of neurology, neurosurgery, and psychiatry,
G J Nijeholt, and M A van Walderveen, and J A Castelijns, and J H van Waesberghe, and C Polman, and P Scheltens, and P F Rosier, and P J Jongen, and F Barkhof
February 2015, Neurology,
G J Nijeholt, and M A van Walderveen, and J A Castelijns, and J H van Waesberghe, and C Polman, and P Scheltens, and P F Rosier, and P J Jongen, and F Barkhof
April 1993, Lancet (London, England),
G J Nijeholt, and M A van Walderveen, and J A Castelijns, and J H van Waesberghe, and C Polman, and P Scheltens, and P F Rosier, and P J Jongen, and F Barkhof
April 2007, Journal of neuroimaging : official journal of the American Society of Neuroimaging,
Copied contents to your clipboard!